品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
罗恩 | R005138-5g | 5g | 现货 | 59-14-3 |
5-溴-2''-脱氧尿苷 5-Bromo-2-deoxyuridine |
99% |
|
|
罗恩 |
R005138-250mg 当天发货 |
250mg | 现货 | 59-14-3 |
5-溴-2''-脱氧尿苷 5-Bromo-2-deoxyuridine |
99% |
|
|
罗恩 |
R005138-1g 当天发货 |
1g | 现货 | 59-14-3 |
5-溴-2''-脱氧尿苷 5-Bromo-2-deoxyuridine |
99% |
|
|
阿拉丁 | B110731-250mg | 250mg | 现货 | 59-14-3 |
5-溴-2'-脱氧尿苷(BUdR) 5-Bromo-2′-deoxyuridine |
≥99% |
|
|
阿拉丁 | B110731-1g | 1g | 现货 | 59-14-3 |
5-溴-2'-脱氧尿苷(BUdR) 5-Bromo-2′-deoxyuridine |
≥99% |
|
|
阿拉丁 | B110731-5g | 5g | 现货 | 59-14-3 |
5-溴-2'-脱氧尿苷(BUdR) 5-Bromo-2′-deoxyuridine |
≥99% |
|
|
阿拉丁 | B110731-25g | 25g | 现货 | 59-14-3 |
5-溴-2'-脱氧尿苷(BUdR) 5-Bromo-2′-deoxyuridine |
≥99% |
|
|
阿拉丁 | B424934-1ml | 1ml | 现货 | 59-14-3 |
5-溴-2'-脱氧尿苷(BUdR) 5-Bromo-2′-deoxyuridine |
10mM in DMSO |
|
|
阿拉丁 | B755698-1g | 1g | 期货,请咨询 | 59-14-3 |
5-溴-2′-脱氧尿苷 5-Bromo-2′-deoxyuridine |
UltraBio™, ≥99% |
|
|
阿拉丁 | B755698-250mg | 250mg | 期货,请咨询 | 59-14-3 |
5-溴-2′-脱氧尿苷 5-Bromo-2′-deoxyuridine |
UltraBio™, ≥99% |
|
|
阿拉丁 | B755698-50mg | 50mg | 期货,请咨询 | 59-14-3 |
5-溴-2′-脱氧尿苷 5-Bromo-2′-deoxyuridine |
UltraBio™, ≥99% |
|
|
韶远 | SY019490-5g | 5g | 现货 | 59-14-3 |
5-溴-2’-脱氧尿苷 5-Bromo-2’-deoxyuridine |
≥95% |
|
|
阿法埃莎 | H27260-250mg | 250mg | 现货 | 59-14-3 |
5-溴-2'-脱氧尿苷, 99% 5-Bromo-2'-deoxyuridine, 99% |
99% |
|
|
阿法埃莎 | H27260-1g | 1g | 现货 | 59-14-3 |
5-溴-2'-脱氧尿苷, 99% 5-Bromo-2'-deoxyuridine, 99% |
99% |
|
|
阿法埃莎 | H27260-5g | 5g | 现货 | 59-14-3 |
5-溴-2'-脱氧尿苷, 99% 5-Bromo-2'-deoxyuridine, 99% |
99% |
|
|
阿法埃莎 | C22859-1GR | 1GR | 现货 | 59-14-3 |
5-溴-2'-脱氧尿苷 5-Bromo-2'-deoxyuridine, 99+... |
|
|
|
阿法埃莎 | C22859-10GR | 10GR | 现货 | 59-14-3 |
5-溴-2'-脱氧尿苷 5-Bromo-2'-deoxyuridine, 99+... |
|
|
|
阿法埃莎 | C22859-2.5GR | 2.5GR | 现货 | 59-14-3 |
5-溴-2'-脱氧尿苷 5-Bromo-2'-deoxyuridine, 99+... |
|
|
|
阿法埃莎 | C22859-500MG | 500MG | 现货 | 59-14-3 |
5-溴-2'-脱氧尿苷 5-Bromo-2'-deoxyuridine, 99+... |
|
|
|
毕得 | BD21654-1g | 1g | 现货 | 59-14-3 |
5-溴-1-((2R,4S,5R)-4-羟基-5-(羟甲... 5-Bromo-1-((2R,4S,5R)-4-hydr... |
98% |
|
|